Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes

Advances in Therapy

Volumn 25, Issue 9, 2008, Pages 884-893

  Gu, Weijun ^a   Lu, Juming ^a   Yang, Guoqing ^a   Dou, Jingtao ^a   Guo, Qinghua ^a   Mu, Yiming ^a   Pan, Changyu ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Diabetes mellitus; Folic acid; Homocysteine; Homocysteine thiolactonase; Methylcobalamin

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CARBOXYLESTERASE; CYANOCOBALAMIN; DRUG DERIVATIVE; FOLIC ACID; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONASE, HUMAN; HOMOCYSTEINE-THIOLACTONASE, HUMAN; MECOBALAMIN; UNCLASSIFIED DRUG; VITAMIN;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; VITAMIN B 12; VITAMINS;

EID: 58149350158     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-008-0095-x     Document Type: Article

References (24)

1. El-Khairy L, Ueland PM, Refsum H, Graham IM, Vollset SE. European Concerted Action Project. Plasma total cysteine as a risk factor for vascular disease: the European Concerted Action Project. Circulation. 2001;103:2544-2549. (Pubitemid 32521962)
2. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134-1146. (Pubitemid 29416243)
3. Hoogeveen EK, Kostense PJ, Beks PJ, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin dependent diabetes mellitus: a population based study. Arterioscler Tromb Vasc Biol. 1998;18:133-138. (Pubitemid 28047610)
4. Jakubowski H. Calcium-dependent human serum homocysteine thiolactone hydrolase. J Biol Chem. 2000;275:3957-3962.
5. Imai Y, Morita H, Kurihara H, et al. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis. 2000;149:435-442. (Pubitemid 30145555)
6. Mackness B, Durrington PN, Abuashia B, Boulton AJ, Mackness MI. Low paraoxonase activity in type 2 diabetes mellitus complicated by retinopathy. Clin Sci (Lond). 2000;98:355-363. (Pubitemid 30145243)
7. Mehta KN, Chag MC, Parlkh KH, et al. Effect of folate treatment on homocysteinemia in cardiac patients: a prospective study. Ind J Pharmacol. 2005;37:13-17. (Pubitemid 40239135)
8. Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care. 2000;23:1108-1112. (Pubitemid 30616797)
9. Finkelstein JD. The metabolism of homocysteine: pathways and regulation. Eur J Pediat. 1998;157(suppl. 2)S40-S44.
10. Mudd SH, Levy HL, Krauss JP. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, et al. eds. The Metabolic and Molecular Bases of Inherited Disease. 8th edition. New York: McGraw-Hill; 2000:2007-2056.
11. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693-2698. (Pubitemid 23350966)
12. Koyama K, Usami T, Takeuchi O, Morozumi K, Kimura G. Efcacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation. Ne phrol Dial Transplant. 2002;17:916-922. (Pubitemid 34521148)
13. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. Br Med J. 1998;316:894-898.
14. Kuwabara S, Nakazawa R, Azuma NI, et al. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med. 1999;38:472-475. (Pubitemid 29330392)
15. Sato Y, Kaji M, Kondo I, Yoshida H, Satoh K, Metoki N. Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: Effect of combined therapy with folic acid and mecobalamine. J Neurol Sci. 2002;15:65-68. (Pubitemid 36153124)
16. Mackness MI, Durrington PN, Mackness B. How high-density lipoprotein protects against the Effects of lipid peroxidation. Curr Opin Lipidol. 2000;11:383-388. (Pubitemid 30616096)
17. Jakubaoski H, Ambrosius W, Pratt JH. Genetic determinants of homocysteine thiolaconase activity in humans: implications for atherosclerosis. FEBS Lett. 2001;491:35-39. (Pubitemid 32171996)
18. Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures: possible mechanism for pathological consequences of elevated homocysteine levels. J Biol Chem. 1997;272:1935-1942. (Pubitemid 27043288)
19. Jakubowski H, Zhang L, Bardeguez A, Aviv A. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ Res. 2000;87:45-51. (Pubitemid 30456934)
20. Kosaka T, Yamaguchi M, Motomura T, Mizuno K. Investigation of the relationship between atherosclerosis and paraoxonase or homocysteine thiolactonase activity in patients with type 2 diabetes mellitus using a commercially available assay. Clin Chim Acta. 2005;359:156-162. (Pubitemid 41116308)
21. Janel N, Robert K, Chabert C, et al. Mouse liver paraoxonase-1 gene expression is downregulated in hyperhomocysteinemia. Tromb Haemost. 2004;92:221-222. (Pubitemid 39010890)
22. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest. 1998;101:1581-1590. (Pubitemid 28198486)
23. Huang RFS, Hsu YC, Lin HL, Yang FL. Folic acid depletion and elevated plasma homocysteine promote oxidative stress in rat livers. J Nutr. 2001;131:33-38. (Pubitemid 32060619)
24. Henning SM, Mckee RW, Seemdseid ME. Vitamins C, E, and A and heme oxygenase in rats fed methyl/folate-defcient diets. Free Radic Biol Med. 1997;23:936-942. (Pubitemid 27402619)